NPHLA Daily
NPHLA Daily
Wednesday, October 28, 2026 · 4-minute read
Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.
Top development today
What changed today in Aesthetics & Longevity: 1 trial update, 1 new study, 1 recall record
NPHLA tracked 3 new official records on this desk today: 1 trial update, 1 new study, 1 recall record. First: New trial registered: Efficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic Alopecia
Metabolic signal
What changed today in Metabolic: 1 new study
NPHLA tracked 1 new official record on this desk today: 1 new study. First: New research in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie: “Mesenchymal stromal cell-based therapies for obesity-associated metabolic complications: Mechanistic insights,…
Regulatory signal
What changed today in Regulatory: 1 trial update, 1 recall record
NPHLA tracked 2 new official records on this desk today: 1 trial update, 1 recall record. First: New trial registered: H24LEAP2 (Investigating the Effects of 24 Hour LEAP2 Infusion in Individuals With Overweight and Obesity)
Aesthetics & Longevity signal
New trial registered: Efficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic Alopecia
Not applicable, BIONEER Corporation. Conditions: Androgenetic Alopecia. Interventions: Low-Concentration CosmeRNA-ARI Anti Hair Loss Tonic; High-Concentration CosmeRNA-ARI Anti Hair Loss Tonic; Vehicle Control Tonic Without CosmeRNA-AR.…
AI & Technology signal
What changed today in AI & Technology: 2 new studies
NPHLA tracked 2 new official records on this desk today: 2 new studies. First: New research in PLOS digital health: “Evaluating an LLM-assisted workflow for clinical documentation: A pilot randomized controlled trial on time and quality”.
One thing worth watching
Comments close: Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and…
October 29, 2026 — verified from the Federal Register comments_close_on.
5 things to know
- What changed today in Aesthetics & Longevity: 1 trial update, 1 new study, 1 recall record
- What changed today in AI & Technology: 2 new studies
- What changed today in Regulatory: 1 trial update, 1 recall record
- What changed today in Metabolic: 1 new study
- New trial registered: Efficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic Alopecia (ClinicalTrials.gov (U.S. National Library of Medicine))
Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.